Pro Medicus Limited (ASX:PME – Get Free Report) insider Alice Williams bought 125 shares of Pro Medicus stock in a transaction that occurred on Friday, February 14th. The shares were acquired at an average price of A$272.69 ($173.69) per share, with a total value of A$34,086.00 ($21,710.83).
Pro Medicus Stock Performance
The company has a debt-to-equity ratio of 1.10, a current ratio of 5.98 and a quick ratio of 4.39. The stock has a market capitalization of $29.16 billion, a P/E ratio of 351.99, a PEG ratio of 3.87 and a beta of 0.56.
Pro Medicus Increases Dividend
The firm also recently announced a Interim dividend, which will be paid on Thursday, March 20th. Investors of record on Thursday, March 20th will be given a dividend of $0.25 per share. This represents a yield of 0.09%. This is a boost from Pro Medicus’s previous Interim dividend of $0.18. The ex-dividend date is Wednesday, February 26th. Pro Medicus’s payout ratio is presently 56.41%.
About Pro Medicus
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.
Read More
- Five stocks we like better than Pro Medicus
- How to buy stock: A step-by-step guide for beginners
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Stock Market Sectors: What Are They and How Many Are There?
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.